SCHEMBL2224684

SCHEMBL2224684

Cc1nc2c(S(=O)(=O)c3ccccc3)nc3[nH]ccc3c2n1C1(C)CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 6/20 0.39
HTR6 P50406 9/20 0.34
JAK2 O60674 3/20 0.33
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
HTR1A P08908 1/20 0.31
DRD2 P14416 1/20 0.31
HTR2A P28223 1/20 0.31
HTR7 P34969 1/20 0.31
CHRM2 P08172 1/20 0.30
CHRM1 P11229 1/20 0.30
PAX8 Q06710 1/20 0.30
KEAP1 Q14145 1/20 0.30
NFE2L2 Q16236 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2224979 0.88 JAK1 (0.46) JAK1JAK2ALDH1A1TYK2JAK3
SCHEMBL2282738 0.86 JAK1 (0.37) JAK1HTR6JAK2TYK2JAK3
SCHEMBL2273331 0.83 JAK1 (0.39) JAK1HTR6JAK2KDM4EALDH1A1
SCHEMBL2273996 0.82 JAK1 (0.41) JAK1JAK2TYK2JAK3
SCHEMBL2274748 0.80 JAK2 (0.53) JAK1HTR6JAK2TYK2JAK3
SCHEMBL2365117 0.76 JAK2 (0.42) JAK1JAK2TYK2JAK3
SCHEMBL2279205 0.75 JAK1 (0.43) JAK1JAK2ALDH1A1TYK2JAK3
SCHEMBL2280645 0.74 JAK1 (0.53) JAK1JAK2KDM4EALDH1A1MAPT
SCHEMBL2277351 0.74 JAK1 (0.53) JAK1JAK2TYK2JAK3
SCHEMBL2227229 0.73 JAK1 (0.45) JAK1JAK2KDM4EALDH1A1TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523957-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. Hoffmann-La Roche AG (CH) 2012-11-21 EP disclosed
WO-2011086053-A1 TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2011-07-21 WO disclosed